Navigation Links
Monoclonal antibody appears effective and safe in asthma Phase IIa trial
Date:5/21/2013

ficant improvements were also reported for other relevant asthma outcomes such as lung function as assessed by forced expiratory volume in one second (FEV1) and morning peak expiratory flow, asthma symptoms and control, as well as, asthma reliever medication use. Many of these improvements were seen when dupilumab was added to ICS/LABA, with efficacy maintained despite background therapy withdrawal.

"Intriguingly," noted Dr. Wenzel, "dupilumab showed substantial efficacy in objective and patient-reported endpoints when added to ICS and LABA and when those therapies were discontinued."

Patients in the study received dupilumab or placebo added to their regular, twice daily dose of fluticasone/salmeterol. At Week 4, patients were instructed to withdraw the LABA (salmeterol). Between Weeks 6 and 9, they tapered off fluticasone, the ICS.

A total of 104 patients, aged 18 to 65, participated in the study. Half received the monoclonal antibody; half received placebo. All had persistent, moderate-to-severe asthma that was not well-controlled by medium to high doses of combined ICS and LABA therapy. The patients also had elevated blood (≥ 300 cells/l) or sputum (≥3%) eosinophils at screening.

The study found no clear change in blood eosinophils with dupilumab therapy; however, other biomarkers decreased, including fractional exhaled nitric oxide, thymus and activation regulated chemokine, immunoglobulin E and eotaxin-3, confirming the biologic activity of dupilumab.

Side effects occurring more frequently in the patients receiving the monoclonal antibody vs. placebo included injection site reactions, nasopharyngitis, nausea and headache, but were not considered severe.

According to Dr. Wenzel, the current study, exhibited a "magnitude and breadth" of efficacy that exceeded other studies of cytokine inhibition in asthma. She and her investigator colleagues speculate that the stronger outcome came as a re
'/>"/>

Contact: Nathaniel Dunford
ndunford@thoracic.org
American Thoracic Society
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial
2. Antibody therapy prevents gastrointestinal damage following radiation exposure in mice
3. Scientists Pinpoint Antibody That May Be Specific to MS Patients
4. NIH scientists map first steps in flu antibody development
5. Elevated Antibody Levels May Predict Rheumatoid Arthritis Risk
6. Antibody-coated stents: Indication of disadvantages
7. Evolution in the antibody factory
8. Scientists ID Antibody That Might Boost Cancer Therapy
9. Your Autoantibody Profile Might Someday Help Spot Illness
10. Off-Label Drug Use Appears Common
11. Exercise Appears to Ease Nerve-Damage Pain in Rat Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... French . ... medicine. A team led by Ludwik Leibler from the ... Didier Letourneur from the Laboratoire Recherche Vasculaire Translationnelle (INSERM/Universits ... the principle of adhesion by aqueous solutions of nanoparticles ... and tissues. This easy-to-use gluing method has been tested ...
(Date:4/17/2014)... have identified new pain relief targets that could ... BBSRC-funded researchers at King,s College London made the ... in the periphery of the body. , Dr ... identifying mechanisms underlying pain generation and our findings ... side effects." , One potential side effect of ...
(Date:4/17/2014)... 17, 2014) Two recent papers by a ... colleagues may help scientists develop treatments or vaccines ... Japanese encephalitis and other disease-causing flaviviruses. , Jeffrey ... molecular genetics at the School of Medicine and ... Medical Institute, and colleagues recently published articles in ...
(Date:4/17/2014)... who treat patients with a severe and progressive ... agonizing treatment decision. , The drug sirolimus can ... shortness of breath. But some patients eventually may ... fatal complications following transplantation. , "It,s a terrible ... of Loyola University Medical Center,s LAM Clinic and ...
(Date:4/17/2014)... of Medicine (BUSM) have discovered that the anti-seizure ... model. The findings, reported in the American ... lead to more effective treatments for alcoholism. , ... leading causes of illness and death in the ... limiting the productivity of workers and necessitating huge ...
Breaking Medicine News(10 mins):Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2
... risk from thiazolidinedione use, study indicates , MONDAY, Feb. ... as thiazolidinediones, which include Avandia and Actos, are at a ... Women who took a thiazolidinedione drug for a year were ... patients who didn,t take the drug, the researchers found. Women ...
... ... Preserve Liquidity -, , QUEBEC CITY, Feb. 15 /PRNewswire-FirstCall/ ... cancer diagnostic tests and delivering laboratory services, today announced changes to ... will be comprised of two business segments: (1) administrative headquarters in ...
... ... electrical stimulation device to their training regimen. , ... San Diego, CA (PRWEB) February 17, 2010 -- ... Team presented by Kenda– a US Continental pro men’s cycling team which competes at ...
... ... turnarounds and improving hospital profitability joins StatCom in a strategic partnership program that helps hospitals ... ... Tom Brunelle FACHE, MBA, to the StatCom team. Previously Brunelle served as EVP and CEO ...
... Facelift surgery, ... is becoming more popular than ever in the battle to slow the progression of facial ... , ... February 15, 2010 – Facelift surgery is the second most popular cosmetic surgical ...
... , SALT LAKE CITY , ... (AAPC) announced its 2010 National Conference being held at the Gaylord Opryland ... event draws thousands of attendees including doctors, medical coders and office/practice managers ... the first time this conference has been approved for 15.75 (CME) ...
Cached Medicine News:Health News:Diabetes Drugs Avandia, Actos Tied to Fractures in Women 2Health News:DiagnoCure announces optimization of entreprise structure 2Health News:DiagnoCure announces optimization of entreprise structure 3Health News:DiagnoCure announces optimization of entreprise structure 4Health News:Compex , Leaders in Electronic Muscle Stimulators, Sponsors the Jelly Belly Cycling Team Presented by Kenda 2Health News:Compex , Leaders in Electronic Muscle Stimulators, Sponsors the Jelly Belly Cycling Team Presented by Kenda 3Health News:Tom Brunelle Joins StatCom as Enterprise VP, Northeast Region 2Health News:Tom Brunelle Joins StatCom as Enterprise VP, Northeast Region 3Health News:Who Needs a Facelift? Plastic Surgeon Dr. Robert Zubowski With the Facts 2Health News:Who Needs a Facelift? Plastic Surgeon Dr. Robert Zubowski With the Facts 3Health News:Who Needs a Facelift? Plastic Surgeon Dr. Robert Zubowski With the Facts 4Health News:AAPC to Host 18th Annual National Conference in Nashville 2Health News:AAPC to Host 18th Annual National Conference in Nashville 3
(Date:1/14/2014)... , Jan. 14, 2014 The Brandeis Medical Center, led ... a premier and affordable laser tattoo removal experience with ... Brandeis, focus is in providing high quality cosmetic services with cutting ... " Southern California has seen a ...
(Date:1/14/2014)... , Jan. 14, 2014 Animal Emergency Critical Care, a ... Leesburg, Virginia is the first in ... chamber. Dr. Susan M. Barnes , Medical ... Barnes and husband, Dr. Cole Taylor , are avid scuba ...
(Date:1/14/2014)... Jan. 14, 2014   Oligomerix, Inc. , a privately held ... Alzheimer,s disease (AD) and related neurodegenerative disorders, announced today ... Valhalla, NY as of January 15, 2014 ... New York Medical College. Oligomerix, which is ...
Breaking Medicine Technology:Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... , ... a new market research report is available in its ... Market Review , http://www.reportlinker.com/p0164247/Insulin-Pumps-External---A-World-Market-Review.html , Insulin ... better control over diabetes, when compared to other forms ...
... , BELLEVUE, Wash., Dec. 1 ... retailer of health, beauty, vision, and pharmacy products, today announced ... orders were the highest in company history. This holiday season ... featured more special offers than in previous years and their ...
Cached Medicine Technology:Reportlinker Adds Insulin Pumps (External) - A World Market Review 2Reportlinker Adds Insulin Pumps (External) - A World Market Review 3Reportlinker Adds Insulin Pumps (External) - A World Market Review 4drugstore.com, inc. Has Best Day Ever on Cyber Monday 2drugstore.com, inc. Has Best Day Ever on Cyber Monday 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: